Q1 2021 Holdings
Filed 2021-05-17 | 94 holdings | $849.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $224.8M | 2,077,200 | 26.5% |
| Avantor Inc(AVTR) | COM | 05352A100 | $144.2M | 4,985,100 | 17.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $116.4M | 1,760,300 | 13.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $60.4M | 427,969 | 7.1% |
| Bausch Health COS Inc(BHC) | COM | 071734107 | $60.0M | 1,891,300 | 7.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $50.2M | 815,100 | 5.9% |
| Alphatec Hldgs Inc(ATEC) | COM NEW | 02081G201 | $36.9M | 2,334,000 | 4.3% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $30.3M | 2,552,000 | 3.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $29.5M | 707,359 | 3.5% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $23.2M | 1,784,000 | 2.7% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $22.7M | 2,447,700 | 2.7% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $19.2M | 1,254,333 | 2.3% |
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $17.5M | 740,000 | 2.1% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.5M | 20,000 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $3.7M | 417,710 | 0.4% |
| Annexon Inc(ANNX) | COM | 03589W102 | $1.9M | 70,000 | 0.2% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $181.5K | 3,650,500 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $121.0K | 1,024,200 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $103.0K | 139,400 | 0.0% |
| Maravai Lifesciences Hldgs I(MRVI) | COM CL A | 56600D107 | $98.4K | 2,761,545 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $88.9K | 1,463,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $86.0K | 3,846,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $82.5K | 2,840,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $81.5K | 475,700 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $80.2K | 577,900 | 0.0% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $78.8K | 598,000 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $78.6K | 7,521,941 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $71.8K | 1,049,800 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $66.8K | 310,900 | 0.0% |
| I MAB(NBP) | SPONSORED ADS | 44975P103 | $64.4K | 1,329,000 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $62.4K | 898,550 | 0.0% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $59.0K | 560,000 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $54.8K | 1,263,300 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $53.5K | 581,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $53.1K | 546,000 | 0.0% |
| Zimmer Biomet Holdings Inc(ZBH) | COM | 98956P102 | $52.2K | 326,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $50.7K | 521,400 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $48.2K | 940,800 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $43.8K | 322,800 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $43.1K | 4,015,000 | 0.0% |
| Abiomed Inc(ABMDEUR) | COM | 003654100 | $42.2K | 132,500 | 0.0% |
| Natera Inc(NTRA) | COM | 632307104 | $40.2K | 395,600 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $38.9K | 1,330,385 | 0.0% |
| Inovio Pharmaceuticals Inc | COM NEW | 45773H201 | $37.2K | 4,004,391 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $37.1K | 9,544,200 | 0.0% |
| Biohaven Pharmactl Hldg Co LCall | COM | G11196905 | $35.8K | 523,100 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $34.6K | 1,472,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $34.4K | 3,500,000 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $32.6K | 135,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $31.3K | 4,317,800 | 0.0% |